Back to all stocks

WTW

9/9 Score

Willis Towers Watson Public Limited Company

Analysis Date: February 16, 2026

Willis Towers Watson Public Limited Company operates as an advisory, broking, and solutions company worldwide. It operates through two segments, Health, Wealth and Career; and Risk and Broking. The company offers actuarial support, plan design, and administrative services for traditional pension and retirement savings plans; plan management consulting, broking, and administration services for health and group benefit programs; and benefits outsourcing services. It also provides advice, data, software, and products to address clients' total rewards and talent issues. In addition, the company offers risk advice, insurance brokerage, and consulting services in the areas of property and casualty, aerospace, construction, and marine. Further, it offers investment consulting and discretionary management services to insurance and reinsurance companies; insurance consulting and technology, risk and capital management, pricing and predictive modeling, financial and regulatory reporting, financial and capital modeling, merger and acquisition, outsourcing, and business management services; wholesale insurance broking services to retail and wholesale brokers; and underwriting and capital management, capital market, and advisory and brokerage services. Additionally, the company provides primary medical and ancillary benefit exchange, and outsourcing services to active employees and retirees in the group and individual markets, as well as delivers healthcare and reimbursement accounts, including health savings accounts, health reimbursement arrangements, flexible spending accounts, and other consumer-directed accounts. The company was formerly known as Willis Group Holdings Public Limited Company and changed its name to Willis Towers Watson Public Limited Company in January 2016. Willis Towers Watson Public Limited Company was founded in 1828 and is based in London, the United Kingdom.

Buffettology Criteria

All 9 of 9 criteria passed

  • High ROE

    Return on Equity > 12%

    Value: 20.1%

  • High ROIC

    Return on Invested Capital > 9%

    Value: 11.5%

  • Cash Machine

    FCF / Assets > 5%

    Value: 5.2%

  • Fair Valuation

    Earnings Yield > 3.5%

    Value: 5.8%

  • Share Buybacks

    Share Count is Dropping

    Value: -3.9%

  • Defensible Moat

    Gross Profit Margin > 40%

    Value: 42.1%

  • Simple Business

    Not in a speculative sector (e.g., Biotech)

    Value: Financial Services

  • Conservative Debt

    Debt to Equity < 1.5

    Value: 0.92x

  • Consistent Growth

    5-Year Growth is Positive

    Value: 113.8%

Analysis Summary

This looks like a solid business, passing all nine of my important criteria. The company demonstrates strong profitability with its high ROE and ROIC, a testament to its efficiently deployed capital. Furthermore, its defensible moat and consistent growth suggest it’s built to last, a quality I always admire in an investment.

Want More Analysis?

Get detailed scores for thousands of stocks and discover your next investment with the Vetted app.

Download Vetted